Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity-Reference-Cited by-同舟云学术

Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity

Published:2024-04 Issue:2 Volume:17 Page:201-210
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunology

Author:

Nantel Sabryna^ORCID,Sheikh-Mohamed Salma,Chao Gary Y.C.,Kurtesi Alexandra,Hu Queenie,Wood Heidi,Colwill Karen^ORCID,Li Zhijie,Liu Ying,Seifried Laurie,Bourdin Benoîte,McGeer Allison,Hardy William R.,Rojas Olga L.,Al-Aubodah Tho-Alfakar^ORCID,Liu Zhiyang^ORCID,Ostrowski Mario A.,Brockman Mark A.^ORCID,Piccirillo Ciriaco A.^ORCID,Quach Caroline^ORCID,Rini James M.,Gingras Anne-Claude,Decaluwe Hélène^ORCID,Gommerman Jennifer L.^ORCID

Funder

Government of Ontario

Canadian Institutes of Health Research

Public Health Agency of Canada

Publisher

Elsevier BV

Reference31 articles.

1. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection;Khoury;Nat. Med.,2021

2. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection;Evans;Sci. Transl. Med.,2022

3. SARS-CoV-2 neutralization with BNT162b2 vaccine Dose 3;Falsey;N. Engl. J. Med.,2021

4. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis;Choi;Nat. Med.,2021

5. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant;Suzuki;Nature,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV;Vaccines;2024-06-16

2. Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination;Vaccines;2024-05-22

3. Differential Adaptive Immune Responses Following SARS-CoV-2 Infection in Children Compared to Adults;2024-04-06